PICKUP Study
Pneumonia in the Immunocompromised: Use of the Karius Test®  for the Detection of Undiagnosed Pathogens

The Karius Test® is a liquid biopsy for infection diseases that utilizes microbial cell-free DNA in plasma to detect over 1000 pathogens causing deep-seated and bloodstream infections.
 
During his presentation Dr. Bergin will provide an overview of the Karius multi-center, prospective study comparing the Karius Test to Standard of Care in immunocompromised (IC) patients being evaluated for pneumonia. The population for this study are IC adults with hematological malignancies and/or hematocrit  (HCT) with suspicion of pneumonia. Results are expected later in 2022.
 
Speaker: Stephen P Bergin, MD - Assistant Professor of Medicine,  Director, Fellowship Training Programs, Pulmonary and Critical Care Medicine, Duke University Health System
 

 

 


Stay up-to-date with Karius

Sign up today to receive notification of future real-world cases of the Karius Test being used by physicians and upcoming events.